Our Patient Commitment

As the end-user of our products and services, we are dedicated to improving the quality of life of our patients suffering from a variety of blood clotting disorders, immune deficiencies, and other illnesses.


Learn more 

The Octapharma mission "for the safe and optimal use of human proteins" conveys the company's focus and dedication to a specialized portfolio of products.

 

 

Explore our products 

News & Press Releases

04-11-2018
Octapharma USA Grant Supports National Conference for Type 3 von Willebrand Disease Patients

‘Making the Connection’ will be held June 22 – 25 in Palm Beach Gardens, Florida

03-01-2018
Octapharma Group publishes 2017 annual results reporting revenue of €1.72 billion and operating income of €349 million

Lachen, Switzerland, March 1st, 2018: Over the last six years, the Octapharma Group has accomplished...